Main Session
Sep
30
SH 12 - Sarcoma and Cutaneous Tumors - Science Highlights
221 - Nivolumab and Ipilimumab with or without Stereotactic Body Radiation in Advanced or Recurrent Merkel Cell Carcinoma: Long Term Results and Biomarker Analysis from a Phase II Multi-Institutional Study
Presenter(s)
Sungjune Kim, MD, PhD - Mayo Clinic Florida, Jacksonville, FL